| Literature DB >> 29429763 |
Ines Boujelben1, Radhouane Gdoura2, Adnane Hammami1.
Abstract
Infective endocarditis (IE) remains a severe and potentially fatal disease demanding sophisticated diagnostic strategies for detection of the causative microorganisms. The aim of the present study was to develop a broad-range 16S ribosomal RNA gene polymerase chain reaction in the routine diagnostic of IE for the early diagnosis of fatal disease. A broad-range PCR technique was selected and evaluated in terms of its efficiency in the diagnosis of endocarditis using 19 heart valves from patients undergoing cardiovascular surgeries at the Habib Bourguiba Hospital of Sfax, Tunisia, on the grounds of suspected IE. The results demonstrated the efficiency of this technique particularly in cases involving a limited number of bacteria since it helped to increase detection sensitivity. The technique proved to be efficient, particularly, in the bacteriological diagnosis of IE in contexts involving negative results from conventional culture methods and other contexts involving bacterial species that were not amenable to identification by phenotypic investigations. Indeed, the sequencing of the partial 16S ribosomal RNA gene revealed the presence of Bartonella henselae, Enterobacter sp., and Streptococcus pyogenes in three heart valves with the negative culture. It should be noted that the results obtained from the polymerase chain reaction-sequencing identification applied to the heart valve and the strain isolated from the same tissue were not consistent with the ones found by the conventional microbiological methods in the case of IE caused by Gemella morbillorum. In fact, the results from the molecular identification revealed the presence of Lactobacillus jensenii. Overall, the results have revealed that the proposed method is sensitive, reliable and might open promising opportunities for the early diagnosis of IE.Entities:
Keywords: Broad-range PCR; Conventional methods; Infective endocarditis; Negative culture; Phenotypic investigations
Mesh:
Substances:
Year: 2018 PMID: 29429763 PMCID: PMC6111453 DOI: 10.1016/j.bjm.2017.03.019
Source DB: PubMed Journal: Braz J Microbiol ISSN: 1517-8382 Impact factor: 2.476
Fig. 1Nested-PCR using the primer pairs MW9/NW17 and NW11/NW12. (A) First-round PCR amplification with primer pairs MW9/NW17. Lane 1 DNA ladder; lane 2–7 contained different suspensions of Streptococcus pneumoniae: lane 2 – 106 CFU/mL; lane 3 – 105 CFU/mL; lane 4 – 104 CFU/mL; lane 5 – 103 CFU/mL; lane 6 – 102 CFU/mL; lane 7 – 10 CFU/mL; lane 8 – negative control. (B) Second-round of PCR amplification with primer pairs NW11/NW12. Lane 1 DNA ladder; lane 2, 3 contained 1 μL from the first-round PCR; lane 2 – suspension 102 CFU/mL of Streptococcus pneumoniae; lane 3 – suspension 10 CFU/mL of Streptococcus pneumoniae; lane 4 contained 1 μL of the negative reaction mixture from the first round. (C) Second-round of PCR amplification of the negative reaction mixture with primer pairs NW11/NW12. Lane 1 DNA ladder; lane 2–6 contained 1 μL of the negative reaction mixture from the first round; lane 2 negative reaction mixture without pretreatment; lane 3–6 negative reaction mixture treated with 1 U, 1.25 U, 1.5 U and 2 U of DNase I, respectively.
Results of broad-range bacterial PCR for heart valves and strain isolated from the same tissue.
| Number of heart valves tested | Valve culture results | PCR and sequencing from the valve | Identity (%) | PCR and sequencing from the isolated strain of the valve | Identity (%) | |
|---|---|---|---|---|---|---|
| 1 | Negative | – | ||||
| 1 | ||||||
| 1 | ||||||
| 1 | Negative | No growth | – | |||
| 1 | Negative | No growth | – | |||
| 1 | Negative | No growth | – | |||
| 12 | Negative | Negative | – | Negative | – | |
| Total | 18 | |||||
Fig. 216S rRNA gene-based phylogenetic dendrogram showing the phylogenetic position of the strain and the valve related to Lactobacillus jensenii. Numbers at the nodes are bootstrap values. Bar, 1% sequence divergence.
Fig. 3PCR-RFLP from the heart valve and the strain isolated from patients with suspected infective endocarditis with the enzymes EcoRI, FokI and DdeI. (A) PCR product amplified from the isolated strain; lane 1 DNA ladder; lane 2 PCR product non-digested; lane 3 PCR product digested with the enzyme EcoRI. (B) PCR product amplified from the heart valve; lane 1 DNA ladder; lane 2 PCR product non-digested; lane 3 PCR product digested with the enzyme Fok I; lane 4 PCR product digested with the enzyme DdeI.